CASI Pharmaceuticals Inc (CASI) COO Cynthia W. Hu Acquires 16,800 Shares
CASI Pharmaceuticals Inc (NASDAQ:CASI) COO Cynthia W. Hu purchased 16,800 shares of CASI Pharmaceuticals stock in a transaction dated Tuesday, January 19th. The stock was acquired at an average price of $0.72 per share, with a total value of $12,096.00. Following the acquisition, the chief operating officer now owns 17,785 shares in the company, valued at approximately $12,805.20. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
CASI Pharmaceuticals Inc (NASDAQ:CASI) traded down 4.05% during midday trading on Thursday, hitting $0.71. 8,056 shares of the stock traded hands. The company’s 50-day moving average is $0.93 and its 200 day moving average is $1.24. CASI Pharmaceuticals Inc has a 12-month low of $0.58 and a 12-month high of $2.13. The firm’s market cap is $23.04 million.
CASI Pharmaceuticals (NASDAQ:CASI) last issued its earnings results on Friday, November 13th. The company reported ($0.05) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.02. On average, analysts anticipate that CASI Pharmaceuticals Inc will post ($0.19) EPS for the current fiscal year.
Separately, HC Wainwright assumed coverage on shares of CASI Pharmaceuticals in a report on Thursday, October 29th. They issued a “buy” rating and a $3.00 price target for the company
